09/17/2026
I have no words to express how grateful God has blessed every sanfilippo child. The FDA approved the first ever treatment for Sanfilippo type A kids!!š Now we wait to find out how parents can get the treatment to their kids and what stipulations the FDA puts on Ultragenx and potential patients. We are beyond ourselves with so many praises to the hands God has placed to achieve what use to be a death sentence for our kids. Now we wait patiently for treatment for types B and C.
The U.S. Food and Drug Administration today approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A.